New hope for lung scarring: ABBV-142 trial opens
NCT ID NCT07230288
First seen Nov 17, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tests an experimental drug called ABBV-142 for people with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes scarring and makes breathing hard. About 165 adults will receive either the drug or a placebo for 52 weeks to see if it safely slows lung function loss. The goal is to find a new treatment that helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre d'Investigation Clinique Mauricie /ID# 277949
RECRUITINGTrois-Rivières, Quebec, G8T 7A1, Canada
-
China Medical University Hospital /ID# 278039
RECRUITINGTaichung, 40447, Taiwan
-
Christie Clinic on University /ID# 277871
RECRUITINGChampaign, Illinois, 61820, United States
-
Hannibal Regional Hospital /ID# 277984
RECRUITINGHannibal, Missouri, 63401, United States
-
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 278029
RECRUITINGKaohsiung City, 807, Taiwan
-
Sec Clinical Research - East - Dothan - Graceland /ID# 278328
RECRUITINGDothan, Alabama, 36305, United States
Conditions
Explore the condition pages connected to this study.